She didn't mention anything about specialty product performance , sounded a bit flat to me I think they're relying almost entirely on these two all important contraceptive FDA approvals . This Generic price deflation is not going to go away , if we need to rely on specialty product performance and if COVID is having adverse impact on them we'll find it difficult to support our commitments . These FDA's are crucial we're out on limb right now , believe if we get at least one approved soon that should keep us out of trouble if future sales are satisfactory . Market would be well aware of the importance (risk) of these pending FDA's approvals IMHO .
MYX Price at posting:
35.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)